FDA clears Daiichi-Sankyo anticoagulant
Seeking Alpha - at Seeking Alpha - Thu Jan 08, 6:55PM CST
PTLA: 34.96 (+3.13), PFE: 34.64 (-0.23), BMY: 60.04 (+0.56), JNJ: 99.62 (+1.18), ISIS: 63.86 (-0.43), MDCO: 29.79 (+0.91), BAX: 70.39 (+0.31), AZN: 69.96 (+0.20), MRK: 58.81 (-0.07), SCLN: 7.85 (+0.08), MSLI: 1.96 (+0.08)
ArQule prostate cancer drug candidate successful in Phase 2
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 9:19AM CST
ARQL: 1.35 (+0.04)
Ad Comm approaches for Daiichi Sankyo anticoagulant
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 12:49PM CDT
The Next Biotech Buyout Stock
Motley Fool Staff - Motley Fool - Fri Oct 10, 7:15AM CDT
Biotech stocks are notoriously volatile, making them best suited for only the most risk-tolerant investors. But for those willing to take the risk, biotech companies can often make a big splash; particularly when a bigger fish gobbles them up....
JNJ: 99.62 (+1.18), PTLA: 34.96 (+3.13), PFE: 34.64 (-0.23), BMY: 60.04 (+0.56), PRTA: 22.89 (+0.13), PBYI: 205.26 (+2.75)